查看购物车
  • Traditional Chinese
  • English
  • Japanese
软组织修復市场（按产品、应用、最终用户和地区）- 预测至 2030 年
市场调查报告书
商品编码
1762822

软组织修復市场（按产品、应用、最终用户和地区）- 预测至 2030 年

Soft Tissue Repair Market by Product (Tissue Patches, Interference Screws, Xenografts, Suture Anchors, Laparoscopic Instruments), Application (Orthopedic, Skin, Dental), End User (Hospitals, Clinics, Ambulatory Surgery Centres) - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 276 Pages | 订单完成后即时交付

价格

软组织修復市场规模预计将从 2025 年的 1,590 万美元成长到 2030 年的 2,050 万美元，2025 年至 2030 年的复合年增长率为 5.1%。

研究范围
调查年份 2023-2030
基准年 2024
预测期 2025-2030
对价单位 金额（十亿美元）
部分 按产品、按应用、按最终用户、按地区
目标区域 北美、欧洲、亚太地区、南美、中东和非洲

软组织修復器械和耗材的主要用途是强化受损组织或透过手术修復断裂或受损的软组织结构。该领域市场的强劲成长得益于多个关键因素，例如软组织修復各个子领域创新产品的普及、年轻人群中运动损伤发生率的上升，以及老龄化人口更容易出现整形外科软组织损伤和疝气。此外，医疗基础设施的进步、政府对医疗体系投入的增加以及可支配收入的提高（尤其是在拉丁美洲和亚太地区），正在显着推动市场扩张。然而，阻碍市场发展的挑战仍然存在，包括有限的保险报销、复杂的监管环境以及与外科手术相关的高昂费用。

2024 年，组织补片/网片占据软组织修復市场最大份额，主要原因在于其广泛应用于疝气修补、骨盆器官脱垂以及需要加固或更换受损软组织的各种重组手术。这些产品占据主导地位的原因在于其结构支撑能力强、手术时间短、患者预后改善。生物和合成网片的日益普及进一步推动了需求成长，因为它们与原生组织的结合更紧密，併发症率更低。网片技术的最新趋势着重于开发轻质、生物相容性和可吸收的聚合物，这显着提高了其临床可接受性并扩大了其应用范围。此外，肥胖率上升、人口老化以及需要组织加固和重组的手术数量增加也促进了该领域的强劲增长。此外，新兴市场对疝气和软组织修復手术的优惠报销条件正在推动补片和网片的普及，从而巩固其在产品系列中的主导地位。

根据应用类型，皮肤修復占软组织修復市场的第三大细分市场。影响这一细分市场的主要因素是需要有效皮肤修復介入的慢性伤口（如糖尿病足溃疡、压疮和腿部静脉溃疡）的盛行率很高。烧伤和创伤性皮肤伤口的增加进一步推动了对先进创伤护理和皮肤移植解决方案的需求。伤口护理技术的最新进展，如胶原蛋白敷料、生长因子疗法和生物工程皮肤替代，显着改善了治疗效果。此外，患者和医疗保健从业者对及时伤口管理重要性的认识不断提高，这对该市场的扩张发挥着重要作用。许多新兴市场扩大慢性伤口护理的保险覆盖范围也促进了软组织修復市场中皮肤修復细分市场的持续成长。

医院和诊所占据了市场占有率的主导地位，这主要是因为它们的患者吞吐量庞大，从而推动了从常规程序到复杂外科手术等各种治疗的需求。这些设施通常是创伤、运动伤害等急性病症以及需要先进软组织修復技术的其他疾病的主要网路基地台。拥有高素质医务人员和先进基础设施的医院通常设有运动医学、普通外科和整形外科等专科，具有全面的诊断能力和外科手术干预能力。此外，大型医院和综合护理诊所享有规模经济，使他们能够采购尖端外科产品和最尖端科技。雄厚的资本和与领先医疗设备製造商建立的关係增强了医院采用和实施创新患者照护解决方案的能力。

多种因素共同作用，使得欧洲占据了软组织修復市场的第二位。强大的医疗基础设施为该地区提供了支撑，使其能够广泛获得先进的外科手术和技术。由于与老龄化相关的疝气和整形外科疾病的增多，老年人口的增长推动了对软组织修復的需求。欧洲国家拥有强大的报销体系和良好的法规环境，促进了创新医疗设备的采用。该地区得到了持续的医疗保健研究资金、早期外科技术的广泛采用以及领先医疗设备公司的成立的支持。随着患者和医疗保健专业人员对微创治疗和术后改善的认识不断提高，欧洲对软组织修復产品的需求正在增长。

本报告研究了全球软组织修復市场，并按产品、应用、最终用户、地理位置和公司概况对市场进行了详细分析。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章市场概述

  • 介绍
  • 市场动态
  • 生态系分析
  • 定价分析
  • 供应链分析
  • 专利分析
  • 价值链分析
  • 技术分析
  • 贸易分析
  • 2025-2026 年重要会议与活动
  • 监管分析
  • 波特五力分析
  • 主要相关人员和采购标准
  • 影响客户业务的趋势/中断
  • 案例研究分析
  • 投资金筹措场景
  • 还款情境分析
  • 最终用户的期望
  • 人工智慧/产生人工智慧对软组织修復市场的影响
  • 2025年美国关税对软组织修復市场的影响

6. 软组织修復市场（依产品）

  • 介绍
  • 组织贴片/网片
  • 腹腔镜器械
  • 其他的

7. 软组织修復市场（按应用）

  • 介绍
  • 疝气修补术
  • 皮肤修復
  • 整形外科软组织修復
  • 牙周软组织修復
  • 乳房重建
  • 硬脑膜修復
  • 阴道吊带
  • 其他的

8. 软组织修復市场（依最终用户划分）

  • 介绍
  • 医院和诊所
  • 门诊手术中心
  • 其他的

9. 软组织修復市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
  • 海湾合作委员会国家

第十章 竞争格局

  • 介绍
  • 主要参与企业的策略/优势
  • 2020-2024年收益分析
  • 2024年市场占有率分析
  • 公司估值矩阵：2024 年主要参与企业
  • 公司估值矩阵：Start-Ups/中小企业，2024 年
  • 估值和财务指标
  • 研发费用
  • 品牌/产品比较
  • 竞争场景

第十一章 公司简介

  • 主要参与企业
    • ARTHREX, INC.
    • SMITH & NEPHEW PLC
    • JOHNSON & JOHNSON SERVICES, INC.
    • BECTON, DICKINSON AND COMPANY（BD）
    • STRYKER
    • MEDTRONIC
    • ZIMMER BIOMET
    • INTEGRA LIFESCIENCES CORPORATION
    • ARTIVION, INC.
    • ORGANOGENESIS INC.
    • LIFENET HEALTH
    • BAXTER
    • TISSUE REGENIX
    • CONMED CORPORATION
    • MERIL LIFE SCIENCES PVT. LTD.
    • RTI SURGICAL
  • 其他公司
    • SAMYANG HOLDINGS CORPORATION
    • AROA BIOSURGERY LIMITED
    • ACERA SURGICAL INC.
    • ORTHOCELL LTD.
    • ACELL, INC.
    • BIOCER ENTWICKLUNGS-GMBH
    • ISTO BIOLOGICS
    • BETATECH MEDICAL
    • MIMEDX GROUP, INC.

第十二章 附录

Product Code: MD 3215

The soft tissue repair market is projected to reach USD 20.5 million by 2030 from USD 15.9 million in 2025, growing at a CAGR of 5.1 % from 2025 to 2030.

Scope of the Report
Years Considered for the Study2023-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Billion)
SegmentsProduct, Application, End user, and Region
Regions coveredNorth America, Europe, Asia Pacific, South America, and Middle East & Africa

The rising demand for soft tissue repair is growing rapidly due to the increasing volume of surgeries and the growing prevalence of severe trauma injuries.

The primary objective of soft tissue repair instruments and consumables is to fortify compromised tissue or surgically address torn or damaged soft tissue structures. The steady market growth in this sector can be attributed to several key factors, including the proliferation of innovative products across various subfields of soft tissue repair, the increasing incidence of sports-related injuries among the youth demographic, and the aging population, which is more prone to orthopedic soft tissue injuries and hernias. Moreover, advancements in healthcare infrastructure, coupled with heightened government investment in health systems and rising disposable incomes, particularly in Latin America and the Asia Pacific regions, are significantly propelling market expansion. However, challenges remain that could hinder progress, such as limited insurance reimbursements, intricate regulatory landscapes, and the high costs associated with surgical interventions.

"By product, the tissue patches/meshes segment accounted for the largest market share in the soft tissue repair market in 2024."

The tissue patches/meshes segment commanded the largest share in the soft tissue repair market in 2024, primarily due to its extensive applications in hernia repair, pelvic organ prolapse, and various reconstructive procedures that necessitate the reinforcement or replacement of compromised soft tissues. The ascendancy of these products can be attributed to their structural support capabilities, reduced operative time, and improved patient outcomes. The rising adoption of both biologic and synthetic meshes, which exhibit enhanced integration with native tissues and a lower incidence of complications, has further fueled demand. Recent advancements in mesh technology, focusing on the development of lightweight, biocompatible, and absorbable polymers, have significantly bolstered their clinical acceptance and expanded their applications. Furthermore, the increasing prevalence of obesity, coupled with an aging demographic and a growing volume of surgeries requiring tissue reinforcement and reconstruction, contributes to the segment's robust growth. Moreover, the favorable reimbursement landscape for hernia and soft tissue repair procedures in developed markets enhances the adoption of patches and meshes, thereby solidifying their leading role within the product portfolio.

"By application, the skin repair segment held the third-largest market share in the soft tissue repair market in 2024."

In the context of application types within the soft tissue repair market, skin repair represents the third-largest segment. A key factor influencing this segment is the high prevalence of chronic wounds, which necessitate effective skin repair interventions, such as those for diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The growing incidence of burn injuries and traumatic skin wounds further escalates the demand for advanced wound care and skin grafting solutions. Recent advancements in wound care technologies, including innovations in collagen dressings, growth factor therapies, and bioengineered skin substitutes, have markedly improved treatment efficacy. Moreover, heightened awareness among both patients and healthcare practitioners regarding the critical importance of timely wound management has played a substantial role in this market's expansion. Coupled with the increasing availability of insurance coverage for chronic wound care in many developed nations, these factors collectively contribute to the sustained growth of the skin repair segment within the broader soft tissue repair market.

"By end user, the hospitals & clinics segment had the largest market share in the soft tissue repair market in 2024."

Hospitals and clinics dominate the market share largely due to their substantial patient throughput, which drives the demand for a wide spectrum of treatments ranging from routine procedures to complex surgical interventions. These institutions are often the primary access points for acute conditions such as trauma, sports-related injuries, and other ailments that require advanced soft tissue repair techniques. Equipped with highly qualified medical personnel and sophisticated infrastructure, hospitals often feature specialized departments-such as sports medicine, general surgery, and orthopedics-that enable comprehensive diagnostic capabilities and surgical interventions. Additionally, larger hospitals and comprehensive care clinics leverage economies of scale, allowing them to procure state-of-the-art surgical products and cutting-edge technologies. Their substantial funding and established relationships with leading medical device manufacturers enhance their ability to adopt and implement innovative solutions in patient care.

"By region, Europe had the second-largest market share in the soft tissue repair market in 2024."

Europe is in the second leading position in the soft tissue repair market due to a combination of elements. A strong healthcare infrastructure backs the region, which facilitates widespread access to advanced surgical procedures and technologies. There is an unnatural need for soft tissue repair offerings brought about by the convergence of extensive age-related hernias and orthopedic diseases with a growing elderly population. European countries have strong reimbursement systems in place, along with favorable regulatory environments, which collectively encourage the uptake of innovative medical devices. The region is topped up by sustained funding for healthcare research, along with widespread adoption of early surgical techniques and the formation of leading medical device firms. The demand for soft tissue repair products in Europe has gained momentum with the increased awareness of patients and healthcare specialists regarding minimally invasive treatments and improved post-surgical results.

A breakdown of the primary participants (supply-side) for the soft tissue repair market referred to for this report is provided below:

  • By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
  • By Designation: C-level-20%, Director Level 35%, and Others-45%
  • By Region: North America-27%, Europe-25%, Asia Pacific-30%, Others-18%.

Key players in the Soft tissue repair market are Smith & Nephew (UK), Arthrex, Inc. (US), Stryker Corporation (US), Johnson & Johnson (US), Medtronic (IE), Lifenet Health, Inc. (US), Becton, Dickinson and Company (US), Integra Lifesciences Corporation (US), Organogenesis Inc. (US), Zimmer Biomet (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK), Aroa Biosurgery Ltd. (NZ), Artivion Inc. (US), CONMED Corporation (US), Meril Lifesciences Pvt Ltd. (India), RTI Surgical (US), Samyang Holdings Corporation (South Korea), Acera Surgical Inc. (US), Orthocell Ltd. (Australia), Biocer Entwicklungs Gmbh (Germany), Isto Biologics (US), Betatech Medical (Turkey), and Mimedx (US)

Research Coverage:

The report analyzes the soft tissue repair market and aims to estimate the market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall soft tissue repair market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

Analysis of key drivers (increasing geriatric population and obesity rate, rising incidence of sports injuries and trauma cases, growing focus on R&D for technologically advanced soft tissue repair product manufacturing, increasing volume of surgeries) restraints (unfavorable reimbursement scenario, high cost of advanced orthodontic treatment and surgical procedures) opportunities (growing adoption of regenerative medicine and biologics in emerging economies, increasing use of combination materials for enhancing product efficacy), challenges (stringent regulatory framework, shortage of skilled surgeons and specialized facilities)

Market Penetration: The report includes extensive information on products offered by the major players in the global soft tissue repair market. It also includes various segments by product, application, end user, and region.

Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global soft tissue repair market.

Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region.

Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global soft tissue repair market.

Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global soft tissue repair market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources of secondary data
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Key objectives of primary research
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Key industry insights
      • 2.1.2.5 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 REVENUE SHARE ANALYSIS
    • 2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS)
    • 2.2.3 TOP-DOWN APPROACH (BASED ON UTILIZATION RATE AND ADOPTION PATTERN)
    • 2.2.4 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
    • 2.2.5 VOLUME ESTIMATION
  • 2.3 GROWTH FORECAST
  • 2.4 DATA TRIANGULATION
  • 2.5 RESEARCH LIMITATIONS
    • 2.5.1 SCOPE-RELATED LIMITATIONS
    • 2.5.2 METHODOLOGY-RELATED LIMITATIONS
  • 2.6 RISK ANALYSIS
  • 2.7 STUDY ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 SOFT TISSUE REPAIR MARKET OVERVIEW
  • 4.2 SOFT TISSUE REPAIR MARKET: REGIONAL MIX
  • 4.3 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT AND COUNTRY (2024)
  • 4.4 SOFT TISSUE REPAIR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.5 SOFT TISSUE REPAIR MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing geriatric population and rising prevalence of obesity
      • 5.2.1.2 Increasing occurrence of sports injuries
      • 5.2.1.3 Rise in R&D investments and launch of technologically advanced products
      • 5.2.1.4 High volume of surgeries and advancements in regenerative technologies
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unfavorable reimbursement scenario
      • 5.2.2.2 High cost of soft tissue repair products and surgical procedures
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing adoption of advanced soft tissue repair products in emerging economies
      • 5.2.3.2 Rising use of combination materials for enhancing product efficacy
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stringent regulatory framework
      • 5.2.4.2 Requirement of skilled personnel for effective use of soft tissue repair products
  • 5.3 ECOSYSTEM ANALYSIS
    • 5.3.1 ROLE IN ECOSYSTEM
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022-2024
    • 5.4.2 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023
    • 5.4.3 AVERAGE SELLING PRICE TREND OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022-2024
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 PATENT ANALYSIS
    • 5.6.1 PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET
    • 5.6.2 TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS
    • 5.6.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN SOFT TISSUE REPAIR MARKET
    • 5.6.4 LIST OF MAJOR PATENTS
  • 5.7 VALUE CHAIN ANALYSIS
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 KEY TECHNOLOGIES
      • 5.8.1.1 Stem cell and regenerative therapies
      • 5.8.1.2 Suture anchors and fixation devices
    • 5.8.2 ADJACENT TECHNOLOGIES
      • 5.8.2.1 3D bioprinting and tissue engineering
      • 5.8.2.2 Regenerative medicine and biologics
    • 5.8.3 COMPLEMENTARY TECHNOLOGIES
      • 5.8.3.1 Wound closure and hemostatic devices
  • 5.9 TRADE ANALYSIS
    • 5.9.1 IMPORT DATA FOR HS CODE 300640, 2019-2023
    • 5.9.2 EXPORT DATA FOR HS CODE 300640, 2019-2023
  • 5.10 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.11 REGULATORY ANALYSIS
    • 5.11.1 REGULATORY FRAMEWORK
      • 5.11.1.1 North America
        • 5.11.1.1.1 US
        • 5.11.1.1.2 Canada
      • 5.11.1.2 Europe
      • 5.11.1.3 Asia Pacific
        • 5.11.1.3.1 China
        • 5.11.1.3.2 Japan
        • 5.11.1.3.3 India
      • 5.11.1.4 Latin America
        • 5.11.1.4.1 Brazil
        • 5.11.1.4.2 Mexico
      • 5.11.1.5 Middle East
      • 5.11.1.6 Africa
    • 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 INTENSITY OF COMPETITIVE RIVALRY
    • 5.12.3 BARGAINING POWER OF BUYERS
    • 5.12.4 BARGAINING POWER OF SUPPLIERS
    • 5.12.5 THREAT OF SUBSTITUTES
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 KEY BUYING CRITERIA
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS
    • 5.15.2 TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC
    • 5.15.3 HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX
  • 5.16 INVESTMENT & FUNDING SCENARIO
  • 5.17 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.18 END-USER EXPECTATIONS
  • 5.19 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET
  • 5.20 IMPACT OF 2025 US TARIFF ON SOFT TISSUE REPAIR MARKET
    • 5.20.1 INTRODUCTION
    • 5.20.2 KEY TARIFF RATES
    • 5.20.3 PRICE IMPACT ANALYSIS
    • 5.20.4 IMPACT ON END-USE INDUSTRIES

6 SOFT TISSUE REPAIR MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 TISSUE PATCHES/MESHES
    • 6.2.1 SYNTHETIC MESHES
      • 6.2.1.1 Cost-effectiveness and minimal risk of donor-to-host infectious disease transmission to aid market growth
    • 6.2.2 BIOLOGICAL MESHES
      • 6.2.2.1 Allografts
        • 6.2.2.1.1 Better biocompatibility to fuel adoption in surgeries and organ transplants
      • 6.2.2.2 Xenografts
        • 6.2.2.2.1 Availability in multiple sizes to make xenografts more viable alternative in soft tissue repair procedures
    • 6.2.3 FIXATION PRODUCTS
      • 6.2.3.1 Suture anchors
        • 6.2.3.1.1 Increasing number of soft tissue injuries and growing need for surgeries to augment segment growth
      • 6.2.3.2 Interference screws
        • 6.2.3.2.1 Rise in injuries among geriatric population and availability of biodegradable interference screws to drive segment
      • 6.2.3.3 Other fixation products
  • 6.3 LAPAROSCOPIC INSTRUMENTS
    • 6.3.1 QUICKER RECOVERY TIME, DECREASED PAIN, LOWER INFECTION RATES, AND REDUCED DISEASE RECURRENCE TO DRIVE MARKET
  • 6.4 OTHER PRODUCTS

7 SOFT TISSUE REPAIR MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 HERNIA REPAIR
    • 7.2.1 RISING ADOPTION OF TENSION-FREE HERNIA REPAIR PROCEDURES TO FUEL MARKET GROWTH
  • 7.3 SKIN REPAIR
    • 7.3.1 RISING CASES OF BURN INJURIES TO SUPPORT MARKET GROWTH
  • 7.4 ORTHOPEDIC SOFT TISSUE REPAIR
    • 7.4.1 INCREASING SPORTS INJURIES AMONG ATHLETES AND RISING INCIDENCE OF ARTHRITIS IN ELDERLY TO FAVOR MARKET GROWTH
  • 7.5 DENTAL SOFT TISSUE REPAIR
    • 7.5.1 RISING NUMBER OF PREVENTIVE AND COSMETIC DENTAL PROCEDURES TO PROPEL MARKET GROWTH
  • 7.6 BREAST RECONSTRUCTION
    • 7.6.1 PREVALENCE OF BREAST CANCER AND INCREASING PATIENTS UNDERGOING MASTECTOMY TO AUGMENT MARKET GROWTH
  • 7.7 DURAL REPAIR
    • 7.7.1 RISING PREVALENCE OF NEUROVASCULAR DISORDERS TO DRIVE MARKET
  • 7.8 VAGINAL SLINGS
    • 7.8.1 INCREASED OCCURRENCE OF STRESS-INDUCED URINARY INCONTINENCE (SUI) TO BOOST MARKET GROWTH
  • 7.9 OTHER APPLICATIONS

8 SOFT TISSUE REPAIR MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS & CLINICS
    • 8.2.1 RISING NUMBER OF REIMBURSED IN-PATIENT PROCEDURES TO DRIVE MARKET
  • 8.3 AMBULATORY SURGICAL CENTERS
    • 8.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAY TO FUEL MARKET GROWTH
  • 8.4 OTHER END USERS

9 SOFT TISSUE REPAIR MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 US to dominate North American soft tissue repair market during forecast period
    • 9.2.3 CANADA
      • 9.2.3.1 High healthcare expenditure and favorable public & private funding to support market growth
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Advanced healthcare infrastructure and favorable surgical reimbursement to propel market growth
    • 9.3.3 FRANCE
      • 9.3.3.1 Well-established healthcare system and high geriatric population to boost market growth
    • 9.3.4 UK
      • 9.3.4.1 Increasing hernia repair and cardiovascular surgeries to stimulate market growth
    • 9.3.5 ITALY
      • 9.3.5.1 Favorable government initiatives and high demand for surgical interventions to support market growth
    • 9.3.6 SPAIN
      • 9.3.6.1 Increasing healthcare budget and rising focus on local medical product manufacturing to drive market
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 JAPAN
      • 9.4.2.1 Strong healthcare system and high geriatric population to favor market growth
    • 9.4.3 CHINA
      • 9.4.3.1 Increasing number of hospitals and rising focus on healthcare policy reforms to stimulate market growth
    • 9.4.4 INDIA
      • 9.4.4.1 Greater healthcare awareness and increased government support to aid market growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Increasing government support and rising healthcare expenditure to support market growth
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Advanced healthcare infrastructure and adoption of minimally invasive surgical technologies to fuel market growth
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Strong public healthcare system and favorable government-led initiatives to aid market growth
    • 9.5.3 MEXICO
      • 9.5.3.1 Increased focus on healthcare modernization and surgical innovation to favor market growth
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 ADVANCED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT POLICIES TO DRIVE MARKET
    • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.7 GCC COUNTRIES
    • 9.7.1 FOCUS ON MEDICAL TOURISM AND AVAILABILITY OF ADVANCED SURGICAL PROCEDURES TO AID MARKET GROWTH
    • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET
  • 10.3 REVENUE ANALYSIS, 2020-2024
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Product footprint
      • 10.5.5.4 Application footprint
      • 10.5.5.5 End-user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 10.6.5.1 Detailed list of key startups/SMEs
      • 10.6.5.2 Competitive benchmarking of startups/SMEs
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS
    • 10.7.1 FINANCIAL METRICS
    • 10.7.2 COMPANY VALUATION
  • 10.8 R&D EXPENDITURE
  • 10.9 BRAND/PRODUCT COMPARISON
  • 10.10 COMPETITIVE SCENARIO
    • 10.10.1 PRODUCT LAUNCHES
    • 10.10.2 DEALS
    • 10.10.3 EXPANSIONS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 ARTHREX, INC.
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 MnM view
        • 11.1.1.3.1 Right to win
        • 11.1.1.3.2 Strategic choices
        • 11.1.1.3.3 Weaknesses & competitive threats
    • 11.1.2 SMITH & NEPHEW PLC
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches
        • 11.1.2.3.2 Deals
        • 11.1.2.3.3 Expansions
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 JOHNSON & JOHNSON SERVICES, INC.
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 BECTON, DICKINSON AND COMPANY (BD)
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 MnM view
        • 11.1.4.3.1 Right to win
        • 11.1.4.3.2 Strategic choices
        • 11.1.4.3.3 Weaknesses & competitive threats
    • 11.1.5 STRYKER
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 MnM view
        • 11.1.5.3.1 Right to win
        • 11.1.5.3.2 Strategic choices
        • 11.1.5.3.3 Weaknesses & competitive threats
    • 11.1.6 MEDTRONIC
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Deals
        • 11.1.6.3.2 Expansions
        • 11.1.6.3.3 Other developments
    • 11.1.7 ZIMMER BIOMET
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Deals
    • 11.1.8 INTEGRA LIFESCIENCES CORPORATION
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
    • 11.1.9 ARTIVION, INC.
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
    • 11.1.10 ORGANOGENESIS INC.
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
    • 11.1.11 LIFENET HEALTH
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
    • 11.1.12 BAXTER
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
    • 11.1.13 TISSUE REGENIX
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
    • 11.1.14 CONMED CORPORATION
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
    • 11.1.15 MERIL LIFE SCIENCES PVT. LTD.
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
    • 11.1.16 RTI SURGICAL
      • 11.1.16.1 Business overview
      • 11.1.16.2 Products offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 SAMYANG HOLDINGS CORPORATION
    • 11.2.2 AROA BIOSURGERY LIMITED
    • 11.2.3 ACERA SURGICAL INC.
    • 11.2.4 ORTHOCELL LTD.
    • 11.2.5 ACELL, INC.
    • 11.2.6 BIOCER ENTWICKLUNGS-GMBH
    • 11.2.7 ISTO BIOLOGICS
    • 11.2.8 BETATECH MEDICAL
    • 11.2.9 MIMEDX GROUP, INC.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 SOFT TISSUE REPAIR MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 3 SOFT TISSUE REPAIR MARKET: RISK ANALYSIS
  • TABLE 4 SOFT TISSUE REPAIR MARKET: STUDY ASSUMPTIONS
  • TABLE 5 UK: INCREASE IN NUMBER OF CARDIAC SURGICAL PROCEDURES PERFORMED
  • TABLE 6 US VS. INDIA: COST OF SURGICAL PROCEDURES, 2023 (USD)
  • TABLE 7 SOFT TISSUE REPAIR MARKET: ROLE IN ECOSYSTEM
  • TABLE 8 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022-2024 (USD)
  • TABLE 9 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023
  • TABLE 10 AVERAGE SELLING PRICE OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022-2024 (USD)
  • TABLE 11 SOFT TISSUE REPAIR MARKET: LIST OF MAJOR PATENTS
  • TABLE 12 IMPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 13 EXPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 14 SOFT TISSUE REPAIR MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 SOFT TISSUE REPAIR MARKET: PORTER'S FIVE FORCES
  • TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%)
  • TABLE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 23 CASE STUDY 1: TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS
  • TABLE 24 CASE STUDY 2: TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC
  • TABLE 25 CASE STUDY 3: HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX
  • TABLE 26 SOFT TISSUE REPAIR MARKET: END-USER EXPECTATIONS
  • TABLE 27 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET
  • TABLE 28 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 29 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 30 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 31 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 SYNTHETIC MESHES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 SYNTHETIC MESHES MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
  • TABLE 34 BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 35 BIOLOGICAL MESHES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 BIOLOGICAL MESHES MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
  • TABLE 37 ALLOGRAFTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 XENOGRAFTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 40 FIXATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 SUTURE ANCHORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 INTERFERENCE SCREWS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 OTHER FIXATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 SOFT TISSUE REPAIR MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 47 HERNIA REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 SKIN REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 ORTHOPEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 DENTAL SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 BREAST RECONSTRUCTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 52 DURAL REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 VAGINAL SLINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 OTHER APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 56 SOFT TISSUE REPAIR MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 SOFT TISSUE REPAIR MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 58 SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 SOFT TISSUE REPAIR MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 60 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 67 US: KEY MACROINDICATORS
  • TABLE 68 US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 69 US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 70 US: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 71 US: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 72 US: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 73 US: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 74 CANADA: KEY MACROINDICATORS
  • TABLE 75 CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 76 CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 77 CANADA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 78 CANADA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 79 CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 80 CANADA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 81 EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 82 EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 83 EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 84 EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 85 EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 86 EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 87 EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 88 GERMANY: KEY MACROINDICATORS
  • TABLE 89 GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 90 GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 91 GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 92 GERMANY: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 93 GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 94 GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 95 FRANCE: KEY MACROINDICATORS
  • TABLE 96 FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 97 FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 98 FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 99 FRANCE: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 100 FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 101 FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 102 UK: KEY MACROINDICATORS
  • TABLE 103 UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 104 UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 106 UK: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 107 UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 108 UK: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 109 ITALY: KEY MACROINDICATORS
  • TABLE 110 ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 111 ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 113 ITALY: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 115 ITALY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 116 SPAIN: KEY MACROINDICATORS
  • TABLE 117 SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 118 SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 119 SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 120 SPAIN: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 121 SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 122 SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 123 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 124 REST OF EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 125 REST OF EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 126 REST OF EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 127 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 128 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 136 JAPAN: KEY MACROINDICATORS
  • TABLE 137 JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 138 JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 139 JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 140 JAPAN: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 141 JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 142 JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 143 CHINA: KEY MACROINDICATORS
  • TABLE 144 CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 145 CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 146 CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 CHINA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 148 CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 149 CHINA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 150 INDIA: KEY MACROINDICATORS
  • TABLE 151 INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 152 INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 153 INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 INDIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 155 INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 156 INDIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 157 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 158 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 159 AUSTRALIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 160 AUSTRALIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 161 AUSTRALIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 162 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 163 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 164 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 165 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 166 SOUTH KOREA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 167 SOUTH KOREA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 SOUTH KOREA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 170 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 171 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 172 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 173 REST OF ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 174 REST OF ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 175 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 176 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 177 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 178 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 179 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 180 LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 181 LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 182 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 183 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 184 BRAZIL: KEY MACROINDICATORS
  • TABLE 185 BRAZIL: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 186 BRAZIL: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 187 BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 BRAZIL: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 189 BRAZIL: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 190 BRAZIL: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 191 MEXICO: KEY MACROINDICATORS
  • TABLE 192 MEXICO: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 193 MEXICO: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 194 MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 195 MEXICO: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 196 MEXICO: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 197 MEXICO: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 198 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 199 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 200 REST OF LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 201 REST OF LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 202 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 203 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 204 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 205 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 206 MIDDLE EAST & AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 207 MIDDLE EAST & AFRICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 208 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 209 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 210 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 211 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 212 GCC COUNTRIES: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 213 GCC COUNTRIES: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 214 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 215 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 216 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET
  • TABLE 217 SOFT TISSUE REPAIR MARKET: DEGREE OF COMPETITION
  • TABLE 218 SOFT TISSUE REPAIR MARKET: REGION FOOTPRINT
  • TABLE 219 SOFT TISSUE REPAIR MARKET: PRODUCT FOOTPRINT
  • TABLE 220 SOFT TISSUE REPAIR MARKET: APPLICATION FOOTPRINT
  • TABLE 221 SOFT TISSUE REPAIR MARKET: END-USER FOOTPRINT
  • TABLE 222 SOFT TISSUE REPAIR MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 223 SOFT TISSUE REPAIR MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION
  • TABLE 224 SOFT TISSUE REPAIR MARKET: PRODUCT LAUNCHES, JANUARY 2022-APRIL 2025
  • TABLE 225 SOFT TISSUE REPAIR MARKET: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 226 SOFT TISSUE REPAIR MARKET: EXPANSIONS, JANUARY 2022-APRIL 2025
  • TABLE 227 ARTHREX, INC.: COMPANY OVERVIEW
  • TABLE 228 ARTHREX, INC.: PRODUCTS OFFERED
  • TABLE 229 SMITH & NEPHEW PLC: COMPANY OVERVIEW
  • TABLE 230 SMITH & NEPHEW PLC: PRODUCTS OFFERED
  • TABLE 231 SMITH & NEPHEW PLC: PRODUCT LAUNCHES, JANUARY 2022-APRIL 2025
  • TABLE 232 SMITH & NEPHEW PLC: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 233 SMITH & NEPHEW PLC: EXPANSIONS, JANUARY 2022-APRIL 2025
  • TABLE 234 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 235 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
  • TABLE 236 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 237 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
  • TABLE 238 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
  • TABLE 239 STRYKER: COMPANY OVERVIEW
  • TABLE 240 STRYKER: PRODUCTS OFFERED
  • TABLE 241 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 242 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 243 MEDTRONIC: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 244 MEDTRONIC: EXPANSIONS: JANUARY 2022-APRIL 2025
  • TABLE 245 MEDTRONIC: OTHER DEVELOPMENTS: JANUARY 2022-APRIL 2025
  • TABLE 246 ZIMMER BIOMET: COMPANY OVERVIEW
  • TABLE 247 ZIMMER BIOMET: PRODUCTS OFFERED
  • TABLE 248 ZIMMER BIOMET: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 249 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 250 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 251 ARTIVION, INC.: COMPANY OVERVIEW
  • TABLE 252 ARTIVION, INC.: PRODUCTS OFFERED
  • TABLE 253 ORGANOGENESIS INC.: COMPANY OVERVIEW
  • TABLE 254 ORGANOGENESIS INC.: PRODUCTS OFFERED
  • TABLE 255 LIFENET HEALTH: COMPANY OVERVIEW
  • TABLE 256 LIFENET HEALTH: PRODUCTS OFFERED
  • TABLE 257 BAXTER: COMPANY OVERVIEW
  • TABLE 258 BAXTER: PRODUCTS OFFERED
  • TABLE 259 TISSUE REGENIX: COMPANY OVERVIEW
  • TABLE 260 TISSUE REGENIX: PRODUCTS OFFERED
  • TABLE 261 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 262 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 263 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 264 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED
  • TABLE 265 RTI SURGICAL: COMPANY OVERVIEW
  • TABLE 266 RTI SURGICAL: PRODUCTS OFFERED
  • TABLE 267 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 268 AROA BIOSURGERY LIMITED: COMPANY OVERVIEW
  • TABLE 269 ACERA SURGICAL INC.: COMPANY OVERVIEW
  • TABLE 270 ORTHOCELL LTD.: COMPANY OVERVIEW
  • TABLE 271 ACELL, INC.: COMPANY OVERVIEW
  • TABLE 272 BIOCER ENTWICKLUNGS-GMBH: COMPANY OVERVIEW
  • TABLE 273 ISTO BIOLOGICS: COMPANY OVERVIEW
  • TABLE 274 BETATECH MEDICAL: COMPANY OVERVIEW
  • TABLE 275 MIMEDX GROUP, INC.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 SOFT TISSUE REPAIR MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 SOFT TISSUE REPAIR MARKET: YEARS CONSIDERED
  • FIGURE 3 SOFT TISSUE REPAIR MARKET: RESEARCH DESIGN
  • FIGURE 4 SOFT TISSUE REPAIR MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 SOFT TISSUE REPAIR MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDE)
  • FIGURE 6 SOFT TISSUE REPAIR MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 SOFT TISSUE REPAIR MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 8 BREAKDOWN OF PRIMARIES (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 BREAKDOWN OF PRIMARIES (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION
  • FIGURE 10 SOFT TISSUE REPAIR MARKET: MARKET SIZE ESTIMATION
  • FIGURE 11 SOFT TISSUE REPAIR MARKET: REVENUE SHARE ANALYSIS (SUPPLY SIDE) (2024)
  • FIGURE 12 SOFT TISSUE REPAIR MARKET: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) (2024)
  • FIGURE 13 SOFT TISSUE REPAIR MARKET: TOP-DOWN APPROACH
  • FIGURE 14 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN SOFT TISSUE REPAIR MARKET
  • FIGURE 15 SOFT TISSUE REPAIR MARKET: CAGR PROJECTIONS (SUPPLY SIDE) (2024)
  • FIGURE 16 SOFT TISSUE REPAIR MARKET: DATA TRIANGULATION
  • FIGURE 17 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 SOFT TISSUE REPAIR MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 REGIONAL SNAPSHOT OF SOFT TISSUE REPAIR MARKET
  • FIGURE 21 INCREASING NUMBER OF HERNIA REPAIR SURGERIES AND RISING R&D INVESTMENTS TO DRIVE MARKET
  • FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 23 JAPAN AND TISSUE PATCHES/MESHES COMMANDED LARGEST MARKET SHARE IN 2024
  • FIGURE 24 CANADA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030
  • FIGURE 25 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 26 SOFT TISSUE REPAIR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 27 SOFT TISSUE REPAIR MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 SOFT TISSUE REPAIR MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTES) FOR SOFT TISSUE REPAIR (JANUARY 2014-APRIL 2025)
  • FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT (COUNTRIES) FOR SOFT TISSUE REPAIR PATENTS, 2014-2025
  • FIGURE 31 SOFT TISSUE REPAIR MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 32 SOFT TISSUE REPAIR MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 35 SOFT TISSUE REPAIR MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • FIGURE 36 SOFT TISSUE REPAIR MARKET: FUNDING AND NUMBER OF DEALS, 2021-2024
  • FIGURE 37 SOFT TISSUE REPAIR MARKET: IMPACT OF AI/GEN AI
  • FIGURE 38 CANADA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
  • FIGURE 39 NORTH AMERICA: SOFT TISSUE REPAIR MARKET SNAPSHOT
  • FIGURE 40 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN SOFT TISSUE REPAIR MARKET, 2020-2024
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SOFT TISSUE REPAIR MARKET (2024)
  • FIGURE 43 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 44 SOFT TISSUE REPAIR MARKET: COMPANY FOOTPRINT
  • FIGURE 45 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 48 SOFT TISSUE REPAIR MARKET: R&D EXPENDITURE OF KEY PLAYERS (2023 VS. 2024)
  • FIGURE 49 SOFT TISSUE REPAIR MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 50 SMITH & NEPHEW PLC: COMPANY SNAPSHOT
  • FIGURE 51 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
  • FIGURE 52 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
  • FIGURE 53 STRYKER: COMPANY SNAPSHOT
  • FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 55 ZIMMER BIOMET: COMPANY SNAPSHOT
  • FIGURE 56 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
  • FIGURE 57 ARTIVION, INC.: COMPANY SNAPSHOT
  • FIGURE 58 ORGANOGENESIS INC.: COMPANY SNAPSHOT
  • FIGURE 59 BAXTER: COMPANY SNAPSHOT
  • FIGURE 60 TISSUE REGENIX: COMPANY SNAPSHOT
  • FIGURE 61 CONMED CORPORATION: COMPANY SNAPSHOT